After the announcement that the Oxford-AstraZeneca vaccines had a “minimal” effect against the mutated Kovid-19 species in the Republic of South Africa and called “B.1.351”, all eyes were turned to the decision of WHO.
A press conference on the use of the Oxford-AstraZeneca vaccine was held at the organization’s headquarters in Geneva, Switzerland.
Head of the Strategic Experts Advisory Group (SAGE), which advises WHO on the use of Kovid-19 vaccines. Alejandro Cravioto, “Even if a strain of (Kovid-19) is in circulation in a country, there is no reason for now not to use this AstraZeneca vaccine to reduce the level of serious disease.” used the expression.
Cravioto also clarified the age groups in which the vaccine can be used, “We recommend that this vaccine be used in people aged 18 and over, without the upper age limit. This means that those over 65 should be vaccinated.” said.
SAGE recommended that the Oxford-AstraZeneca vaccine be given in two doses, 8 to 12 weeks apart.
The USA will examine the WHO reports!
WHO WILL MAKE A FINAL EVALUATION
Head of WHO Vaccines and Vaccination Department Dr. Kate O’Brien pointed out that SAGE’s recommendation is temporary, and that “final evaluation and decision” regarding the AstraZeneca vaccine can be announced at the meetings to be held on February 12 and 15.
Chief expert of the WHO Scientific Committee, Dr. Soumya Swaminathan also stated that the news in the media is not true that the Republic of South Africa will stop using the Oxford-AstraZeneca vaccine.
Swaminathan emphasized that this country will continue to use the Oxford-AstraZeneca vaccine to “gather evidence and data.”
Expressing that the vaccine in question is one of the priority vaccines for the Kovid-19 Vaccines Global Access Program (COVAX), Swaminathan noted that hundreds of millions of doses of vaccine to be provided will be distributed all over the world under COVAX.
Cononavirus statement from the WHO team in Wuhan
AT LEAST 337 MILLION DOSE VACCINES FOR POOR COUNTRIES IN THE FIRST 6 MONTHS OF 2021
The Minister of Health of the Republic of South Africa Zweli Mkhize stated that they temporarily stopped the use of the vaccine developed by Oxford University and AstraZeneca.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus, in a statement on February 8, pointed out that it is too early to reach a final judgment for the vaccine.
The Global Vaccine and Vaccination Association (GAVI) reported that under COVAX, at least 337 million doses of Kovid-19 vaccine were allocated to poor countries in the first 6 months of 2021 and it is planned to be distributed to countries as of the end of February.
Supertotobet0142.com giriş sonrası hızlı bahis oynayabilir ve hemen kazanç sahibi olacak işlemlerde bulunabilirsiniz. Supertotobet0142.com casino oynama sitesinde yer alan masa oyunlarından da 3D ve sanal şekilde kazanç sağlayabilirsiniz. Supertotobet0142.com canlı casino oyun seçenekleri yüklemesiz sunuluyor. saniyesinde açılan oyunlarda hemen kazanç sağlayabilirsiniz.